Loading company
BGM · Nasdaq · Healthcare · Drug Manufacturers Specialty and Generic
$7.88+2.3%Nov 13 close
Figures through March 31, 2026, from the 6-K filed August 28, 2026
From the company’s own 6-K filing.
BGM Group Ltd. has no earnings call transcript available.
The quote and the company description come from the 6-K BGM Group Ltd. filed on August 28, 2026 with its results; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.